HIV infections fall by 73% in bi and gay British men

pharmafile | January 16, 2020 | News story | Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland 

Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% since 2014 in the UK.

This has largely been attributed to the rise in the use of pre-exposure prophylaxis (Prep). It is a pill that is taken daily, or prior to sex, to prevent HIV infection. If taken consistently it protects cells in the body and disables the virus to stop it multiplying, so it won’t spread even if a condom isn’t used during sex.

A study by the UK Medical Research Council found that there was an 86% fall in new HIV infections among gay men who used Prep compared to those who didn’t. Many in the sexual-health sector say Prep can be 100% effective if taken correctly.

Advertisement

The drug is currently free on the NHS in Scotland for high-risks patients but not in the England. Its impact trial first began in September 2017 and at least 15 people in England have tested HIV positive while waiting for a place on the trial.

Health Secretary Matt Hancock said this latest study showed the UK was on track to achieve its goal of ending HIV transmission by 2030. He said: “I feel very strongly that we must end HIV transmission. HIV has brought untold hurt and suffering to so many, so it is encouraging to see transmissions continue to fall across the UK.”

Many critics believe the UK is acting to slowly to help men with the disease, and they feel the data for the success of Prep means it should be fast-tracked for general patients in England.

Conor Kavanagh

 

Related Content

NHS England approves delayed-release treatment for rare kidney disease

NHS England has approved the routine commissioning of delayed-release mercaptamine bitartrate for eligible patients with …

Product value to pathway impact: What the CVD Modern Service Framework means for pharma

By Sabina Syed and Ewan Maule The Cardiovascular Disease Modern Service Framework1(CVD MSF) begins with a …

Scottish NHS hospital adopts light-activated therapy to reduce surgical infections

NHS Golden Jubilee has become the first hospital in Scotland to introduce a light-activated nasal …

The Gateway to Local Adoption Series

Latest content